Good Pharma Manufacturing : Gmp Fda Gdp 483 Source.
FDA 483, MAPP & NEWS
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:03:50
- More information
Informações:
Synopsis
Valsartin API NDEA / NDMA contamination, MAPP 5014.1 Risk Based Site Selection Model. OSS 483 Inspection. Good Pharma Manufacturing covers many pharmaceutical topics from cGMP's, GDP's, compliance, training, drug recalls, 483's, the history of the pharmaceutical industry, management, case studies and more.